CUE BIOPHARMA INC. - COMMON STOCK

Cue Biopharma Announces Pricing of Approximately $20 Million Public Offering

14 4月 2025 21:23:10 条件 Nasdaq GlobeNewswire

Cue Biopharma Announces Proposed Public Offering

14 4月 2025 16:05:00 条件 Nasdaq GlobeNewswire

Cue Biopharma to Host Business Update Call and Webcast

14 4月 2025 16:02:00 条件 Nasdaq GlobeNewswire

Boehringer Ingelheim and Cue Biopharma partner to develop next-generation treatment for autoimmune and inflammatory diseases

14 4月 2025 16:00:00 条件 Nasdaq GlobeNewswire

Cue Biopharma Reports Fourth Quarter and Full Year 2024 Financial Results and Business Highlights

31 3月 2025 15:20:00 条件 Nasdaq GlobeNewswire

Cue Biopharma Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

29 11月 2024 15:30:00 条件 Nasdaq GlobeNewswire

Cue Biopharma to Participate in Fireside Discussion at the Piper Sandler 36th Annual Healthcare Conference

25 11月 2024 07:00:00 条件 Nasdaq GlobeNewswire

Cue Biopharma Reports Third Quarter 2024 Financial Results and Recent Business Highlights

14 11月 2024 15:05:00 条件 Nasdaq GlobeNewswire

Cue Biopharma Announces Strategic Organizational Transition

14 11月 2024 07:00:09 条件 Nasdaq GlobeNewswire

Cue Biopharma to Participate in Fireside Chat at the Stifel 2024 Healthcare Conference

12 11月 2024 07:00:00 条件 Nasdaq GlobeNewswire

Cue Biopharma Presents Positive Updated Data from its Phase 1 Trials of CUE-101 and CUE-102 in Head and Neck Cancer and WT1 Positive Cancers at the SITC 39th Annual Meeting

08 11月 2024 12:30:00 条件 Nasdaq GlobeNewswire

Cue Biopharma Announces Upcoming Scientific Presentations at the Society for Immunotherapy of Cancer’s (SITC) 39th Annual Meeting

04 10月 2024 08:00:00 条件 Nasdaq GlobeNewswire

Cue Biopharma Announces Pricing of $12.0 Million Public Offering

26 9月 2024 22:26:30 条件 Nasdaq GlobeNewswire

Cue Biopharma Announces Proposed Public Offering

26 9月 2024 22:10:15 条件 Nasdaq GlobeNewswire

Cue Biopharma Announces Proposed Public Offering

26 9月 2024 15:27:02 条件 Nasdaq GlobeNewswire

Cue Biopharma Appoints Industry Veteran Lucinda Warren as Chief Business Officer

09 9月 2024 07:00:00 条件 Nasdaq GlobeNewswire

Cue Biopharma to Present at The Promise of Interleukin-2 Therapy Conference

03 9月 2024 07:00:00 条件 Nasdaq GlobeNewswire

Cue Biopharma Reports Second Quarter 2024 Financial Results and Recent Business Highlights

19 8月 2024 15:05:00 条件 Nasdaq GlobeNewswire

Cue Biopharma to Host Business Update Call and Webcast

13 8月 2024 07:00:01 条件 Nasdaq GlobeNewswire

Cue Biopharma Announces Strategic Prioritization of Autoimmune Programs Enabling Optimization of Workforce and Reduction of Capital Requirements

25 7月 2024 15:05:00 条件 Nasdaq GlobeNewswire